ATSDR. (2003). Toxicological Profile for Pyrethrins and Pyrethroids. U.S. Department of Health and Human Services Agency for Toxic Substances and Disease Registry, September, 328. https://www.atsdr.cdc.gov/toxprofiles/tp155.pdf (Accessed January 6, 2021)
Boffetta, P., & Desai, V. (2018). Exposure to Permethrin and Cancer Risk: a systematic review. Critical Reviews in Toxicology, 48(6), 433–442.
Boverhof, D. R., & Zacharewski, T. R. (2006). Toxicogenomics in Risk Assessment: Applications and Needs. Toxicological Sciences, 89(2), 352–360.
CaliforniaEPA. (1994). Permethrin (Tick Repellent) Risk Characterization Document (Revised), Medical Toxicology and Worker Health and Safety Branches Department of Pesticide Regulation California Environmental Protection Agency.
Carmichael, N., Bausen, M., Boobis, A. R., Cohen, S. M., Embry, M., Fruijtier-Pölloth, C., Greim, H., Lewis, R., Meek, M. E., Mellor, H., Vickers, C., & Doe, J. (2011). Using Mode of Action Information to Improve Regulatory Decision-Making: An ECETOC/ILSI RF/HESI workshop overview. Critical Reviews in Toxicology, 41(3), 175–186.
Cheung, C., Akiyama, T. E., Ward, J. M., Nicol, C. J., Feigenbaum, L., Vinson, C., & Gonzalez, F. J. (2004). Diminished Hepatocellular Proliferation in Mice Humanized for the Nuclear Receptor Peroxisome Proliferator-activated Receptor α. Cancer Research, 64(11), 3849–3854.
Cohen, S. M. (2010). Evaluation of Possible Carcinogenic Risk to Humans Based on Liver Tumors in Rodent Assays:The Two-year Bioassay Is No Longer Necessary. Toxicologic Pathology, 38(3), 487–501.
Cohen, S. M., & Arnold, L. L. (2011). Chemical Carcinogenesis. Toxicological Sciences, 120(SUPPL.1), 76–92.
Cohen, S. M., & Arnold, L. L. (2016). Critical Role of Toxicologic Pathology in a Short-term Screen for Carcinogenicity. Journal of Toxicologic Pathology, 29(4), 215–227.
Cohen, S. M., Meek, M. E., Klaunig, J. E., Patton, D. E., & Fenner-Crisp, P. A. (2003). The Human Relevance of Information on Carcinogenic Modes of Action: Overview. Critical Reviews in Toxicology, 33(6), 581–589.
Corton, J. C., Cunningham, M. L., Hummer, B. T., Lau, C., Meek, B., Peters, J. M., Popp, J. A., Rhomberg, L., Seed, J., & Klaunig, J. E. (2014). Mode of Action Framework Analysis for Receptor-mediated Toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study. Critical Reviews in Toxicology, 44(1), 1–49.
Corton, J. C., Peters, J. M., & Klaunig, J. E. (2018). The PPARα-Dependent Rodent Liver Tumor Response is not Relevant to Humans: addressing misconceptions. Archives of Toxicology, 92(1), 83–119.
DeLuca, J. G., Doebber, T. W., Kelly, L. J., Kemp, R. K., Molon-Noblot, S., Sahoo, S. P., Ventre, J., Wu, M. S., Peters, J. M., Gonzalez, F. J., & Moller, D. E. (2000). Evidence for Peroxisome Proliferator-Activated Receptor (PPAR)α-Independent Peroxisome Proliferation: Effects of PPARγ/δ-Specific Agonists in PPARα-null Mice. Molecular Pharmacology, 58(3), 470–476.
Elcombe, C. R., Peffer, R. C., Wolf, D. C., Bailey, J., Bars, R., Bell, D., Cattley, R. C., Ferguson, S. S., Geter, D., Goetz, A., Goodman, J. I., Hester, S., Jacobs, A., Omiecinski, C. J., Schoeny, R., Xie, W., & Lake, B. G. (2014). Mode of Action and Human Relevance Analysis for Nuclear Receptor-mediated Liver Toxicity: A Case Study with Phenobarbital as a Model Constitutive Androstane Receptor (CAR) activator. Critical Reviews in Toxicology, 44(1), 64–82.
Friedrich, A., & Olejniczak, K. (2011). Evaluation of Carcinogenicity Studies of Medicinal Products for Human Use Authorised via the European Centralised Procedure (1995- 2009). Regulatory Toxicology and Pharmacology, 60(2), 225–248.
Gonzalez, F. J., & Shah, Y. M. (2008). PPARα: Mechanism of Species Differences and Hepatocarcinogenesis of Peroxisome Proliferators. Toxicology, 246(1), 2–8.
Haines, C., Elcombe, B. M., Chatham, L. R., Vardy, A., Higgins, L. G., Elcombe, C. R., & Lake, B. G. (2018). Comparison of the Effects of Sodium Phenobarbital in Wild Type and Humanized Constitutive Androstane Receptor (CAR)/pregnane X receptor (PXR) Mice and in Cultured Mouse, Rat and Human Hepatocytes. Toxicology, 396– 397(November 2017), 23–32.
Haseman, J. K. (1983). A Reexamination of False-positive Rates for Carcinogenesis Studies. Fundam. Appl. Toxicol., 3, 334–339.
Hasmall, S. C., & Roberts, R. A. (1999). The Perturbation of Apoptosis and Mitosis by Drugs and Xenobiotics. Pharmacology and Therapeutics, 82(1), 63–70.
Hays, T., Rusyn, I., Burns, A. M., Kennett, M. J., Ward, J. M., Gonzalez, F. J., & Peters, J. M. (2005). Role of Peroxisome Proliferator-activated Receptor-α (PPARα) in Bezafibrate-induced Hepatocarcinogenesis and Cholestasis. Carcinogenesis, 26(1), 219–227.
Hirose, Y., Nagahori, H., Yamada, T., Deguchi, Y., Tomigahara, Y., Nishioka, K., Uwagawa, S., Kawamura, S., Isobe, N., Lake, B. G., & Okuno, Y. (2009). Comparison of the Effects of the Synthetic Pyrethroid Metofluthrin and Phenobarbital on CYP2B Form Induction and Replicative DNA Synthesis in Cultured Rat and Human Hepatocytes. Toxicology, 258(1), 64–69.
Holsapple, M. P., Pitot, H. C., Cohen, S. H., Boobis, A. R., Klaunig, J. E., Pastoor, T., Dellarco, V. L., & Dragan, Y. P. (2006). Mode of Action in Relevance of Rodent Liver Tumors to Human Cancer Risk. Toxicological Sciences, 89(1), 51–56.
IARC. (1996). Clofibrate. In Monographs on the Evaluation of Carcinogenic Risks To Humans, 66, 391–426.
IARC. (1999). Hormonal Contraception and Post-Menopausal Hormonal Therapy. In Monographs on the Evaluation of Carcinogenic Risks To Humans, 72.
JMPR. (1999). Pesticide Residues in Food. http://www.inchem.org/documents/jmpr/jmpmono/v99pr07.htm (Accessed January 6, 2021)
Kaneko, H. (2010). Pyrethroid Chemistry and Metabolism. In Hayes’ Handbook of Pesticide Toxicology (Third Eds.), pp.1635–1663, Academic Press, New York.
Klaunig, J. E., Babich, M. A., Baetcke, K. P., Cook, J. C., Corton, J. C., David, R. M., DeLuca, J. G., Lai, D. Y., McKee, R. H., Peters, J. M., Roberts, R. A., & Fenner-Crisp, P. A. (2003). PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance. Critical Reviews in Toxicology, 33(6), 655–780.
Kondo, M., Kikumoto, H., Osimitz, T. G., Cohen, S. M., Lake, B. G., & Yamada, T. (2020). An Evaluation of the Human Relevance of the Liver Tumors Observed in Female Mice Treated with Permethrin Based on Mode of Action. Toxicological Sciences, 175(1), 50– 63.
Kondo, M., Miyata, K., Nagahori, H., Sumida, K., Osimitz, T. G., Cohen, S. M., Lake, B. G., & Yamada, T. (2019). Involvement of Peroxisome Proliferator-activated Receptor- alpha in Liver Tumor Production by Permethrin in the Female Mouse. Toxicological Sciences, 168(2), 572–596.
Kunimatsu, T., Yamada, T., Ose, K., Sunami, O., Kamita, Y., Okuno, Y., Seki, T., & Nakatsuka, I. (2002). Lack of (Anti-) androgenic or Estrogenic Effects of Three Pyrethroids (Esfenvalerate, Fenvalerate, and Permethrin) in the Hershberger and Uterotrophic Assays. Regulatory Toxicology and Pharmacology, 35(2), 227–237.
Lake, B. G. (1987). Preparation and Characterization of Microsomal Fractions for Study of Xenobiotic Metabolism. In Biochemical Toxicology (K. Snell, and B. Mullock, Eds.), pp. 183–216. IRL Press, Oxford.
Lake, B. G. (2009). Species Differences in the Hepatic Effects of Inducers of CYP2B and CYP4A Subfamily Forms: Relationship to Rodent Liver Tumour Formation. Xenobiotica, 39, 582–596.
Lake, B. G. (2018). Human Relevance of Rodent Liver Tumour Formation by Constitutive Androstane Receptor (CAR) Activators. Toxicology Research, 7(4), 697–717.
Lake, B. G., Price, R. J., & Osimitz, T. G. (2015). Mode of Action Analysis for Pesticide- induced Rodent Liver Tumours Involving Activation of the Constitutive Androstane Receptor: Relevance to Human Cancer Risk. Pest Management Science, 71(6), 829– 834.
Lee, S. S., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez- Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995). Targeted Disruption of the Alpha Isoform of the Peroxisome Proliferator-activated Receptor Gene in Mice Results in Abolishment of the Pleiotropic Effects of Peroxisome Proliferators. Molecular and Cellular Biology, 15(6), 3012–3022.
Maronpot, R. R., Yoshizawa, K., Nyska, A., Harada, T., Flake, G., Mueller, G., Singh, B., Ward, J. M., & Botts, S. (2010). Liver Enlargement - STP regulatory policy papers: Hepatic Enzyme Induction: Histopathology. Toxicologic Pathology, 38(5), 776–795.
Matsuyama, R., Kitamoto, S., & Tomigahara, Y. (2018). Lack of Genotoxic Potential of Permethrin in Mice Evaluated by the Comet Assay and Micronucleus Test. Toxicological and Environmental Chemistry, 100(1), 92–102.
McGregor, D., Boobis, A., Binaglia, M., Botham, P., Hoffstadt, L., Hubbard, S., Petry, T., Riley, A., Schwartz, D., & Hennes, C. (2010). Guidance for the Classification of Carcinogens Under the Globally Harmonised System of Classification and Labelling of Chemicals (GHS). Critical Reviews in Toxicology, 40(3), 245–285.
Meek, M. E., Bucher, J. R., Cohen, S. M., Dellarco, V., Hill, R. N., Lehman-McKeeman, L. D., Longfellow, D. G., Pastoor, T., Seed, J., & Patton, D. E. (2003). A Framework for Human Relevance Analysis of Information on Carcinogenic Modes of Action. Crit. Rev. Toxicol., 33, 591–653.
Mikata, K., Isobe, N., & Kaneko, H. (2012). Biotransformation and Enzymatic Reactions of Synthetic Pyrethroids in Mammals. In Pyrethroids (N. Matsuo and T. Mori, Eds.), Vol. 314, pp. 113–135. Springer, Berlin/Heidelberg, Germany.
OECD. (2012). Guidance Document 116 on the Conduct and Design of Chronic Toxicity and Carcinogenicity Studies, supporting Test Guidelines 451, 452 and 453, 2nd ed, series on testing and assessment, no.116. Organisation for Economic Co-operation and Development (OECD), Paris, France.
Okuda, Y., Kushida, M., Sumida, K., Nagahori, H., Nakamura, Y., Higuchi, H., Kawamura, S., Lake, B. G., Cohen, S. M., & Yamada, T. (2017). Editor’s highlight: Mode of Action Analysis for Rat Hepatocellular Tumors Produced by the Synthetic Pyrethroid Momfluorothrin: Evidence for Activation of the Constitutive Androstane Receptor and Mitogenicity in Rat Hepatocytes. Toxicological Sciences, 158(2), 412–430.
Parker, L. (1982). Toward Hydroxylation. Pharmacology, 110–115.
Parzefall, W., Erber, E., Sedivy, R., & Schulte-Hermann, R. (1991). Testing for Induction of DNA Synthesis in Human Hepatocyte Primary Cultures by Rat Liver Tumor Promoters. Cancer Research, 51, 1143–1147.
Peters, J. M., Aoyama, T., Cattley, R. C., Nobumitsu, U., Hashimoto, T., & Gonzalez, F. J. (1998). Role of Peroxisome Proliferator-activated Receptor α in Altered Cell Cycle Regulation in Mouse Liver. Carcinogenesis, 19(11), 1989–1994.
Peters, J. M., Cattley, R. C., & Gonzalez, F. J. (1997). Role of PPARα in the Mechanism of Action of the Nongenotoxic Carcinogen and Peroxisome Proliferator Wy-14,643. Carcinogenesis, 18(11), 2029–2033.
Quist, E. M., Boorman, G. A., Cullen, J. M., Maronpot, R. R., Remick, A. K., Swenberg, J. A., Freshwater, L., & Hardisty, J. F. (2019). Reevaluation of Hepatocellular Neoplasms in CD-1 Mice from a 2-year Oral Carcinogenicity Study with Permethrin. Toxicologic , Paris Pathology, 47(1), 11–17.
Runge, D. M., Runge, D., Dorko, K., Pisarov, L. A., Leckel, K., Kostrubsky, V. E., Thomas, D., Strom, S. C., & Michalopoulos, G. K. (1999). Epidermal Growth Factor- and Hepatocyte Growth Factor-receptor Activity in Serum-free Cultures of Human Hepatocytes. Journal of Hepatology, 30(2), 265–274.
Rusiecki, J. A., Patel, R., Koutros, S., Beane-Freeman, L., Landgren, O., Bonner, M. R., Coble, J., Lubin, J., Blair, A., Hoppin, J. A., & Alavanja, M. C. R. (2009). Cancer Incidence among Pesticide Applicators Exposed to Permethrin in the Agricultural Health Study. Environmental Health Perspectives, 117(4), 581–586.
Seglen, P. O. (1976). Preparation of Isolated Rat Liver Cells. Methods in Cell Biology, 13(C), 29–83.
Tateno, C., Yamamoto, T., Utoh, R., Yamasaki, C., Ishida, Y., Myoken, Y., Oofusa, K., Okada, M., Tsutsui, N., & Yoshizato, K. (2015). Chimeric Mice with Hepatocyte- humanized Liver as an Appropriate Model to Study Human Peroxisome Proliferator- activated Receptor-α. Toxicologic Pathology, 43(2), 233–248.
Thoolen, B., Maronpot, R. R., Harada, T., Nyska, A., Rousseaux, C., Nolte, T., Malarkey, D. E., Kaufmann, W., Küttler, K., Deschl, U., Nakae, D., Gregson, R., Vinlove, M. P., Brix, A. E., Singh, B., Belpoggi, F., & Ward, J. M. (2010). Proliferative and Nonproliferative Lesions of the Rat and Mouse Hepatobiliary System. Toxicologic Pathology, 38(7 SUPPL.), 5–81.
Tominaga, H., Ishiyama, M., Ohseto, F., Sasamoto, K., Hamamoto, T., Suzuki, K., & Watanabe, M. (1999). A Water-soluble Tetrazolium Salt Useful for Colorimetric Cell Viability Assay. Analytical Communications, 36(2), 47–50.
U.S.FDA. (2001). Center for Drug Evaluation and Research, Guidance for Industry: Statistical Aspects of the Design, Analysis, and Interpretation of Chronic Rodent Carcinogenicity Studies of Pharmaceuticals. May. https://www.fda.gov/regulatory- information/search-fda-guidance-documents/statistical-aspects-design-analysis-and- interpretation-chronic-rodent-carcinogenicity-studies (Accessed January 6, 2021)
Wiemann, C., Goettel, M., Vardy, A., Elcombe, B. M., Elcombe, C. R., Chatham, L. R., Wang, H., Li, L., Buesen, R., Honarvar, N., Treumann, S., Marxfeld, H., Groeters, S., & Lake, B. G. (2019). Metazachlor: Mode of Action Analysis for Rat Liver Tumour Formation and Human Relevance. Toxicology, 426(April), 152282.
Wood, C. E., Hukkanen, R. R., Sura, R., Jacobson-Kram, D., Nolte, T., Odin, M., & Cohen, S. M. (2015). Scientific and Regulatory Policy Committee (SRPC) Review*:Interpretation and Use of Cell Proliferation Data in Cancer Risk Assessment. Toxicologic Pathology, 43(6), 760–775.
World Health Organization. (2020). World Malaria Report. In World Health: Vol.WHO/HTM/GM (Issue December).
Yamada, T. (2018). Case Examples of an Evaluation of the Human Relevance of the Pyrethroids/pyrethrins-induced Liver Tumours in Rodents Based on the Mode of Action. Toxicology Research, 7(4), 681–696.
Yamada, T., Kikumoto, H., Lake, B. G., & Kawamura, S. (2015). Lack of Effect of Metofluthrin and Sodium Phenobarbital on Replicative DNA Synthesis and Ki-67 mRNA Expression in Cultured Human Hepatocytes. Toxicology Research, 4(4), 901– 913.
Yamada, T., Kondo, M., Miyata, K., Ogata, K., Kushida, M., Sumida, K., Kawamura, S., Osimitz, T. G., Lake, B. G., & Cohen, S. M. (2017). An Evaluation of the Human Relevance of the Lung Tumors Observed in Female Mice Treated with Permethrin Based on Mode of Action. Toxicological Sciences, 157(2), 465–486.
Yamada, T., Okuda, Y., Kushida, M., Sumida, K., Takeuchi, H., Nagahori, H., Fukuda, T., Lake, B. G., Cohen, S. M., & Kawamura, S. (2014). Human Hepatocytes Support the Hypertrophic But not the Hyperplastic Response to the Murine Nongenotoxic Hepatocarcinogen Sodium Phenobarbital in an in vivo Study Using a Chimeric Mouse with Humanized Liver. Toxicological Sciences, 142(1), 137–157.
Yang, Q., Nagano, T., Shah, Y., Cheung, C., Ito, S., & Gonzalez, F. J. (2008). The PPARα- Humanized Mouse: A Model to Investigate Species Differences in Liver Toxicity Mediated by PPARα. Toxicological Sciences, 101(1), 132–139.
食品安全委員会. (2019). ペルメトリン 農薬・動物用医薬品評価書.
住友化学(株). (2006). 技術誌. Development of ‘ Olyset ® net ’ as a Tool for Malaria Control. https://www.sumitomo-chem.co.jp/rd/report/files/docs/20060200_xff.pdf (Accessed January 6, 2021)
住友化学(株). (2009). 農薬抄録.
住友化学(株). (2020). 「オリセット®ネット」を通じた支援. https://www.sumitomochem.co.jp/sustainability/social_contributions/olysetnet/ (Accessed January 6, 2021)
福島昭治、前川昭彦. (2005). 放射線および環境化学物質による発癌.
山岡聖典, 花元克巳, 恭宏稲, 片岡隆浩, 睦川辺, 佐野正展および氏福亜矢子. (2003). 化学発がんの非遺伝毒性的メカニズムの解明に関する最近の動向. 岡山大学医学部保健学科紀要, Vol. 14, pp. 1–14.